Global proton Opportunity to expand proton therapy installations in Latin America, with Brazil signaling a first Proteus ONE center; potential to offer turnkey proton therapy systems and related services to new regional markets.

Strategic partnerships Recent collaboration with Telix to distribute ARTMS QIS and QUANTM irradiation tech indicates a pathway to cross-sell radiopharma production capabilities and solid-target technology to cyclotron users worldwide.

Expansion capacity Customer expansion through multi-site radiopharmacy networks (RLS sites in the U.S.) and ongoing cyclotron deployments suggest demand for scalable production platforms and service packages.

Leadership & governance Board strengthenments and leadership realignment signal a growth-first strategy; leverage executive focus to upsell enterprise-grade solutions, maintenance contracts, and financing options.

Sustainability edge B Corp certification and environmental/social performance emphasis can be leveraged to position offerings for hospitals and labs pursuing sustainability-aligned procurement and payer incentives.